Back to search
Anti-Psychotic
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anti-Psychotic trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Anti-Psychotic trials you may qualify forPrevious study found that some NMDA-enhancing agent was able to augment efficacy of clozapine for clinical symptoms but not cognitive function in the treatment…
Previous studies found that some NMDA-enhancing agents were able to improve clinical symptoms of patients with chronic schizophrenia. In addition, several drugs…
This research project will explore negative symptoms of schizophrenia, such as motivational deficits, by examining the relationship between inflammation and rew…
This study purpose is to conduct a confirmatory double-blind randomized controlled trial in an inpatient setting of the effects of a tightly controlled gluten-f…
Negative symptoms and cognitive deficits are two partially-related features of schizophrenia which have a major negative impact on social function and objective…